# Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity

Study · id `cardio:ct-nct01888315` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01888315](<https://clinicaltrials.gov/study/NCT01888315>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01888315

Browse, organ or system: Heart; Blood vessels; Kidneys  
Browse, condition area: High blood pressure; Heart rhythm problems; Heart failure; Kidney connections  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT01888315. Non-randomized; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2021-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT01888315, source copy `cardio:ctgov-nct01888315-2013-06-27`, retrieved 2026-10-26)
- Start date: 2011-01 (registry gives no type) (ClinicalTrials.gov record NCT01888315, source copy `cardio:ctgov-nct01888315-2013-06-27`, retrieved 2026-10-26)
- Primary completion: 2021-01 (anticipated) (ClinicalTrials.gov record NCT01888315, source copy `cardio:ctgov-nct01888315-2013-06-27`, retrieved 2026-10-26)
- Completion: 2021-01 (anticipated) (ClinicalTrials.gov record NCT01888315, source copy `cardio:ctgov-nct01888315-2013-06-27`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT01888315, source copy `cardio:ctgov-nct01888315-2013-06-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01888315-2013-06-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity
- Condition: Hypertension
- Condition: Heart Failure
- Condition: Chronic Kidney Disease
- Condition: Diabetes
- Condition: Heart Rhythm Disorders
- Intervention (Device): Renal denervation with Symplicity Flex Medtronic/Ardian
- Intervention (Device): Renal denervation with EnligHTN St. Jude Medical
- Intervention (Device): Renal denervation with Paradise Recor
- Intervention (Device): Renal denervation with V2 Vessix
- Lead sponsor: University Hospital, Saarland
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University Hospital, Saarland (`cardio:org-university-hospital-saarland`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in Hypertension (`cardio:pubmed-38572643`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 357039a3f1742aef42d4cc2665420f92d74df9cfa3913e549711268d594e54d2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
